Permeaderm, Inc.
Stedical Scientific is a healthcare technology company dedicated to bringing disruptive innovation to healthcare. It focuses on acquiring, nurturing, and growing organizations with life-changing products that impact large markets globally. The company aims to expand extensively in the China market, in addition to marketing products in the U.S. and Europe, with a mission to improve patient and clinician experiences while delivering economic value to investors and shareholders. Stedical is involved in tissue engineering technology and develops proprietary innovative medical solutions, including the FDA-cleared PermeaDerm platform for wound management.
Industries
Nr. of Employees
small (1-50)
Permeaderm, Inc.
2888 Loker Ave. East, Ste. 319, Carlsbad, CA 92010
Patents
Products
Biosynthetic wound matrix (variable-porosity primary dressing)
A multilayer biosynthetic primary dressing designed as a temporary skin substitute for management of partial-thickness burns, donor sites, coverage of meshed autograft, chronic and acute wounds; incorporates a gas-/exudate-diffusing membrane, adjustable porosity, a 3D micro-scaffold and hydrophilic bio-coating.
Biosynthetic wound matrix (variable-porosity primary dressing)
A multilayer biosynthetic primary dressing designed as a temporary skin substitute for management of partial-thickness burns, donor sites, coverage of meshed autograft, chronic and acute wounds; incorporates a gas-/exudate-diffusing membrane, adjustable porosity, a 3D micro-scaffold and hydrophilic bio-coating.
Services
Market development, distributor partnerships and international market expansion for medical device products in wound care and burns.
Design and operational support for multi-center clinical studies, investigator symposia, site selection and enrollment management.
Research, iterative product development and platform advancement for biosynthetic wound matrices and related medical devices.
Support for regulatory submissions, quality management system implementation (ISO 13485) and product verification activities.
Market development, distributor partnerships and international market expansion for medical device products in wound care and burns.
Design and operational support for multi-center clinical studies, investigator symposia, site selection and enrollment management.
Research, iterative product development and platform advancement for biosynthetic wound matrices and related medical devices.
Support for regulatory submissions, quality management system implementation (ISO 13485) and product verification activities.
Expertise Areas
- Tissue engineering and biosynthetic skin substitutes
- Wound care and burn management
- Clinical trial management and investigator engagement
- Regulatory compliance and 510(k) submissions
Key Technologies
- Biosynthetic skin-substitute technology
- Variable-porosity primary dressing design
- Silicone membrane diffusion layers for gas and exudate control
- 3D biomimetic micro-scaffold materials
News & Updates
Stedical Scientific Announcing the First Patients Enrolling into its PermeaDerm® Clinical Trials in the US and China
Stedical Scientific launched multi-center clinical trials for PermeaDerm® in the US and China, with initial enrollment and ongoing studies demonstrating the product's potential in burn and wound care.
Stedical Scientific Hosts Clinical Trial Investigator Symposium
The company hosted a symposium in Shanghai with top clinicians and experts to discuss clinical trial design and development of bio-engineered skin substitutes.
Dr. Aubrey Woodroof, Delivers Keynote Lecture at 2020 Boswick Burn and Wound Care Symposium
Dr. Woodroof discussed his 49-year quest to create a skin substitute functioning as well or better than human skin, highlighting the development of PermeaDerm.
Innovation in skin-healing products from new company, Stedical Scientific
An article highlighting the company's focus on skin-healing products and its acquisition of PermeaDerm Inc.
Stedical Scientific Announces Completion of Acquisition of PermeaDerm, Inc.
Stedical Scientific completed its acquisition of PermeaDerm, Inc., aiming to develop and commercialize its innovative wound care products globally.
Stedical Scientific Announcing the First Patients Enrolling into its PermeaDerm® Clinical Trials in the US and China
Stedical Scientific launched multi-center clinical trials for PermeaDerm® in the US and China, with initial enrollment and ongoing studies demonstrating the product's potential in burn and wound care.
Stedical Scientific Hosts Clinical Trial Investigator Symposium
The company hosted a symposium in Shanghai with top clinicians and experts to discuss clinical trial design and development of bio-engineered skin substitutes.
Dr. Aubrey Woodroof, Delivers Keynote Lecture at 2020 Boswick Burn and Wound Care Symposium
Dr. Woodroof discussed his 49-year quest to create a skin substitute functioning as well or better than human skin, highlighting the development of PermeaDerm.
Innovation in skin-healing products from new company, Stedical Scientific
An article highlighting the company's focus on skin-healing products and its acquisition of PermeaDerm Inc.
Stedical Scientific Announces Completion of Acquisition of PermeaDerm, Inc.
Stedical Scientific completed its acquisition of PermeaDerm, Inc., aiming to develop and commercialize its innovative wound care products globally.